urolithin C

6H- dibenzo[b,d]pyran-6-one, 3,8,9-trihydroxy- 3,8,9- trihydroxybenzo[c]chromen-6-one PubMed: In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepaten(®) Formulation. PubMed: The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells. PubMed: Pilot walnut intervention study of urolithin bioavailability in human volunteers. PubMed: Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils. PubMed: Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials. PubMed: Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. PubMed: Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. PubMed: Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome. PubMed: Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion. PubMed: The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. PubMed: Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. PubMed: Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. PubMed: Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.